Article
TERT promoter mutation analysis for blood-based diagnosis and monitoring of gliomas
2020-09-04
Abstract excerpt
Liquid biopsy offers a minimally invasive tool to diagnose and monitor the heterogeneous molecular landscape of tumors over time and therapy. Gliomas have been challenging to sample with blood-based liquid biopsy due to low levels of circulating tumor-derived nucleic acid, and prior efforts have shown specific point mutations in less than 5% of glioma patients. Detection of TERT promoter mutations (C228T, C250T) i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 116d7b3c-773c-5890-859b-370d7a54e6f3
- DOI
- 10.1101/2020.09.03.20135236
